4995 related articles for article (PubMed ID: 401850)
1. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase.
Iwata K; Takeuchi T
J Invest Dermatol; 1977 Feb; 68(2):88-92. PubMed ID: 401850
[TBL] [Abstract][Full Text] [Related]
2. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
Tomita Y; Moro S; Seiji M
J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
[No Abstract] [Full Text] [Related]
3. Electrophoretic characterization of tyrosinase in the coated vesicles of malignant melanoma.
Mojamdar M; Imokawa G; Mishima Y
J Dermatol; 1979 Feb; 6(1):5-8. PubMed ID: 110860
[No Abstract] [Full Text] [Related]
4. Transfer of tyrosinase to melanosomes in Harding-Passey mouse melanoma.
Tomita Y; Hariu A; Kato C; Seiji M
Arch Biochem Biophys; 1983 Aug; 225(1):75-85. PubMed ID: 6412634
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of tyrosinase isozymes of cultured malignant melanoma cells during the recovery period following interrupted melanogenesis induced by glycosylation inhibitors.
Imokawa G; Mishima Y
J Invest Dermatol; 1984 Sep; 83(3):196-201. PubMed ID: 6432920
[TBL] [Abstract][Full Text] [Related]
6. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
Jimbow K; Jimbow M; Chiba M
J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
[TBL] [Abstract][Full Text] [Related]
7. False dopa reaction in studies of mammalian tyrosinase: some characteristics and precautions.
White R; Hu F; Roman NA
Stain Technol; 1983 Jan; 58(1):13-9. PubMed ID: 6410541
[TBL] [Abstract][Full Text] [Related]
8. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
Imokawa G; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
[No Abstract] [Full Text] [Related]
9. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
Miranda M; Botti D
Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
[TBL] [Abstract][Full Text] [Related]
10. Solubilizing effect of Trition X-100 on melanosome tyrosinase in hamster pigmented melanoma.
Blagoeva PM
Neoplasma; 1977; 24(3):291-4. PubMed ID: 408715
[TBL] [Abstract][Full Text] [Related]
11. Analysis of tyrosinases as asparagin-linked oligosaccharides by concanavalin A lectin chromatography: appearance of new segment of tyrosinases in melanoma cells following interrupted melanogenesis induced by glycosylation inhibitors.
Imokawa G; Mishima Y
J Invest Dermatol; 1985 Aug; 85(2):165-8. PubMed ID: 3926905
[TBL] [Abstract][Full Text] [Related]
12. Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells.
Imokawa G; Mishima Y
Cancer Res; 1982 May; 42(5):1994-2002. PubMed ID: 6802485
[TBL] [Abstract][Full Text] [Related]
13. Conversion of particulate tyrosinase to soluble form and to desialylated tyrosinase in human malignant melanoma.
Nishioka K
FEBS Lett; 1977 Aug; 80(1):225-8. PubMed ID: 408193
[No Abstract] [Full Text] [Related]
14. Characteristics of tyrosinase in B16 melanoma.
White R; Hu F
J Invest Dermatol; 1977 May; 68(5):272-6. PubMed ID: 16062
[TBL] [Abstract][Full Text] [Related]
15. Action of trypsin and detergents on tyrosinase of normal and malignant melanocytes.
Quevedo WC; Holstein TJ; Bienieki TC
Proc Soc Exp Biol Med; 1975 Dec; 150(3):735-40. PubMed ID: 813238
[TBL] [Abstract][Full Text] [Related]
16. Detection of mouse tyrosinase with a monoclonal antibody MAT-1 against human tyrosinase.
Suzuki S; Takimoto H; Masui S; Kato T; Shibata K; Tomita Y; Shibahara S; Nakano H
Pigment Cell Res; 1996 Dec; 9(6):298-303. PubMed ID: 9125753
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of mouse tyrosinase by enzyme-linked immunosorbent assay.
Ishiguro S; Yamamoto H; Yanai N; Takeuchi T
J Biochem; 1986 Apr; 99(4):1081-5. PubMed ID: 3086301
[TBL] [Abstract][Full Text] [Related]
18. Aggregation equilibria of tyrosinase of Harding-Passey mouse melanoma.
Garcia-Borron JC; Solano F; Iborra JL; Lozano JA
Biochem J; 1985 May; 228(1):95-101. PubMed ID: 3924035
[TBL] [Abstract][Full Text] [Related]
19. Half-lives of tyrosinase isozymes from Harding-Passey mouse melanoma.
Martinez JH; Solano F; Peñafiel R; Lozano JA
Cancer Lett; 1988 Jan; 38(3):339-46. PubMed ID: 3127037
[TBL] [Abstract][Full Text] [Related]
20. [Structural factors and the DOPA oxidase activity of membrane-bound tyrosinase].
Shtol'ko VN; Kol'tover VK; Il'in AV; Vasil'eva LS; Bogdanov GN
Dokl Akad Nauk SSSR; 1979; 244(4):1009-12. PubMed ID: 104854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
